ArticleACS nano2024

Targeting Tumor-Associated Macrophages with the Immune-Activating Nanomedicine for Achieving Strong Antitumor Activity with Rapid Clearance from the Body.

Yosuke Ota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.